e-learning
resources
Vienna 2012
Monday, 03.09.2012
Aspects of clinical asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Real life application of basophil activation test: A real challenge for diagnosis and treatment monitoring of atopy-related diseases?
F. Garziano, M. Bocchino, E.M. Borriello, A. Stanziola, C. La Rocca, F. Carbone, F. Flavio, A. Sanduzzi, F. Perna (Naples, Italy)
Source:
Annual Congress 2012 - Aspects of clinical asthma
Session:
Aspects of clinical asthma
Session type:
Thematic Poster Session
Number:
2390
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Garziano, M. Bocchino, E.M. Borriello, A. Stanziola, C. La Rocca, F. Carbone, F. Flavio, A. Sanduzzi, F. Perna (Naples, Italy). Real life application of basophil activation test: A real challenge for diagnosis and treatment monitoring of atopy-related diseases?. Eur Respir J 2012; 40: Suppl. 56, 2390
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Real life experience with omalizumab and mepolizumab in severe asthma : do patient baseline features preclude effectiveness comparison ?
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Year: 2019
Does timeliness of diagnosis influence survival and treatment response in idiopathic pulmonary fibrosis? Real- world results from the EMPIRE registry.
Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside
Year: 2017
Real life study showing the epidemiological profile and adherence to treatment of patients with severe allergic asthma in use of omalizumab in the past year.
Source: International Congress 2018 – Biomarkers for evaluating asthma
Year: 2018
Capability of classical diagnostic procedure in relation with specific inhalation challenge for conclusive diagnosis in allergic asthma
Source: Annual Congress 2008 - Asthma and inhalation injuries at work
Year: 2008
Real prevalence of severe asthma in developing countries – Is the diagnosis correct?
Source: Virtual Congress 2020 – Clinical parameters in severe asthma
Year: 2020
Real current situation of management and for patient with asthma at community
Source: Annual Congress 2012 - Diagnostic insights and decision making in primary care
Year: 2012
Air travel in chronic lung disease: can clinical variables predict response to the hypoxic challenge test?
Source: Virtual Congress 2021 – Hypoxia, exercise and respiratory function in pathophysiological conditions
Year: 2021
Conversion of tuberculosis screening tests during biological therapy in patients with rheumatic diseases: what’s beyond screening values?
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018
Do laboratory challenge tests for occupational asthma represent what happens in the workplace?
Source: Eur Respir J, 51 (6) 1800059; 10.1183/13993003.00059-2018
Year: 2018
Effectiveness evaluation of anti-IgE treatment at 3rd year: Real life Turkey data
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
Sputum induction for assessment of biomarkers in early development of new drugs for respiratory disease in a proof of concept setting
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Control of asthma in real life: still a valuable goal?
Source: Eur Respir Rev 2015; 24: 361-369
Year: 2015
Discrepancy of non-invasive inflammatory markers and lung function tests to current level of clinical control in childhood asthma
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009
Do measures of bronchial responsiveness add information in diagnosis and monitoring of patients with asthma?
Source: Eur Respir J 2001; 18: 439-441
Year: 2001
LATE-BREAKING ABSTRACT: Real life impact of long acting beta-2-agonist withdrawal in controlled step 3 asthma patients
Source: International Congress 2016 – Novel strategies on COPD and asthma management
Year: 2016
Clinical asthma phenotypes in the real world: opportunities and challenges
Source: Breathe 2015; 11:186-193
Year: 2015
Blood eosinophilia in patients with COPD, a real life evaluation
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018
Patients with asthma and comorbid allergic rhinitis: Is optimal quality of life achievable in real life?
Source: Annual Congress 2011 - Asthma: risk factors and comorbidities
Year: 2011
Real world residual disease manifestations after 2-years anti-IL-5 treatment for severe asthma
Source: Virtual Congress 2020 – Severe asthma phenotypes and outcomes
Year: 2020
Do we need new asthma control tests?
Source: Eur Respir J 2014; 44: 1116-1118
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept